TMCnet9d
Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ®
Juan Carlos Jaramillo, M.D., Chief Medical Officer of Valneva, commented, “This latest approval is a further recognition of IXCHIQ ® ’s strong product profile and the medical need for a chikungunya ...
Business Insider10d
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
M.D., Chief Medical Officer of Valneva, commented, “This latest approval is a further recognition of IXCHIQ ® ’s strong product profile and the medical need for a chikungunya vaccine.
Yahoo Finance9d
Valneva’s chikungunya vaccine wins UK approval
Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), allowing the single-dose vaccine to be made available for adults.
Mena FN9d
Valneva Receives Marketing Authorization In The UK For The World’S First Chikungunya Vaccine, IXCHIQ®
1 Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® - Valneva 2 Valneva Announces U.S. FDA Approval of World's First Chikungunya ...
PMLiVE9d
MHRA approves Valneva’s chikungunya vaccine Ixchiq for use in adults
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use in adults. Ixchiq is now the first vaccine approved in the UK to prevent ...
Pharmabiz8d
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq
Valneva SE, a specialty vaccine company, announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for the world’s ...